Nissan Chemical Corporation Revises Consolidated Earnings Guidance for the Six Months Ending September 30, 2022 and Year Ending March 31, 2023
August 08, 2022 at 02:00 am EDT
Share
Nissan Chemical Corporation revised consolidated earnings guidance for the six months ending September 30, 2022 and year ending March 31, 2023. For the six months, the company expects net sales of ¥105.4 billion compared to previous guidance of ¥101.1 billion, operating income of ¥27.6 billion compared to previous guidance of ¥26.0 billion, net income attributable to owners of parent of ¥21.2 billion or ¥150.12 earnings per share compared to previous guidance of ¥19.3 billion or ¥136.77 earnings per share.
For the year, the company expects net sales of ¥223.3 billion compared to previous guidance of ¥219.0 billion, operating income of ¥55.1 billion compared to previous guidance of ¥53.5 billion, net income attributable to owners of parent of ¥41.7 billion or ¥295.83 earnings per share compared to previous guidance of ¥39.6 billion or ¥280.90 earnings per share.
Nissan Chemical Corporation specializes in manufacturing and marketing chemical products. Net sales break down by family of products as follows:
- performance materials (30.2%): polyimide resins, colloids, silicas, inorganic materials, etc. for the manufacturng of electronic products (semiconductors, LCD displays, etc.);
- agrochemical products (25.1%): insecticides (Sanmite, Starmite, Mito-Kohne, Leimay and Ikaruga brands), herbicides (Roundup, Targa, Sirius and Permit), fertilizers, etc.;
- basic chemicals and fine chemicals (11.3%): melamine, sulfuric acid, nitric acid, ammonia, etc.;
- pharmaceutical products (2.9%): primarily for treatment of angina, hypertension, cholesterol, etc.;
- other (25.8%).
The remaining sales (25.8%) are from the chemicals trading activity.
Net sales break down geographically as follows: Japan (47.7%), China (14.5%), Korea (10.3%), Asia (13.8%), Europe and the United States (13.7%).